Due to the COVID-19 Corona virus pandemic, the European Society for Translational Medicine (EUSTM) has revised the 2021 congress format to a virtual event. EUSTM took this initiative to ensure the health and safety of our global delegates. The congress will address & discuss novel therapeutics in solid tumors.
EUSTM cordially invites you to attend the 8th Annual Congress of the European Society for Translational Medicine on novel therapeutics in solid tumors (EUSTM-2021) during 20-26 September, 2021. This Virtual Congress will focus on the key principles of Translational Medicine: Bench side, Bed side and Public Health. The interdisciplinary forum will address current challenges, highlight novel solutions and identify critical hurdles as they apply to solid tumors.
The congress will be virtual in nature and will highlight high profile presentations and E-posters by the global multidisciplinary experts from 20-26 September, 2021. The congress will be hosted at the virtual platform. The delegates will have access to latest developments and updates by the industry and vendors.
EUSTM-2021 cordially invites industry partners actively engaged on any type of solid tumors therapeutics to apply for the sponsorship opportunities. Due to virtual congress, the following slots would proivde great opportunity to showcase services/products to global multidisciplinary audience. Following types of opportunities are available on ‘first–come, first–served basis.